NK 631在头颈癌中的临床应用（作者译）
[Clinical application of NK 631 to head-and-neck cancers (author's transl)].
作者信息
Ogawa Y, Omata T, Imaizumi H, Shiga H, Ouchi J
出版信息
Jpn J Antibiot. 1979 Jan;32(1):115-20.
PMID:84881
Abstract
NK 631, a new antibiotic of bleomycin analogue, was applied to the treatment of 15 patients with head-and-neck cancers. The results obtained were slightly better than bleomycin-treated cases. For the side effect of NK 631, there were no lung disorders in all patients.
摘要
博来霉素类似物新型抗生素NK 631应用于15例头颈癌患者的治疗。所获结果略优于接受博来霉素治疗的病例。关于NK 631的副作用，所有患者均未出现肺部疾病。
Zotero 插件